From METTL3 PROTACs to pyroptosis-coupled design: a medicinal chemistry agenda for next-generation targeted degraders
Crossref DOI link: https://doi.org/10.1007/s00044-026-03535-4
Published Online: 2026-03-06
Published Print: 2026-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vijayasimha, M. https://orcid.org/0000-0003-2038-7006
Text and Data Mining valid from 2026-03-06
Version of Record valid from 2026-03-06
Article History
Received: 28 November 2025
Accepted: 23 February 2026
First Online: 6 March 2026
Competing interests
: The authors declare no competing interests.